Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Vail

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Nature Reviews. Neurology|January 9, 2013
Clarification of conclusions from the ACT NoW trialAudrey Bowen, Anne Hesketh, Emma Patchick, et al.
Rheumatology Advances in Practice|December 21, 2022
Feasibility study of mobile phone photography as a possible outcome measure of systemic sclerosis-related digital lesionsAdrian K Davison, Graham Dinsdale, Paul New, et al.
Journal of Neuroinflammation|November 27, 2012
Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infectionStephen J Hopkins, Catherine J McMahon, Navneet Singh, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 19, 2021
Use of Pulmonary Computed Tomography for Evaluating Suspected Stroke-Associated PneumoniaAmit K Kishore, Anand Devaraj, Andy Vail, et al.
BMJ Open|September 24, 2020
Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort studyCarlo Berzuini, Cathal Hannan, Andrew King, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Stroke|March 24, 2018
SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 TrialCraig J Smith, Sharon Hulme, Andy Vail, et al.
Frontiers in Endocrinology|March 25, 2014
Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPA(R.)Mars Skae, Hima Bindu Avatapalle, Indraneel Banerjee, et al.
BMC Neurology|January 17, 2004
Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcomeCraig J Smith, Hedley C A Emsley, Carole M Gavin, et al.
Journal of Neuroimmunology|June 12, 2003
An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosisHedley C A Emsley, Craig J Smith, Carole M Gavin, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Nature Reviews. Neurology|January 9, 2013
Clarification of conclusions from the ACT NoW trialAudrey Bowen, Anne Hesketh, Emma Patchick, et al.
Rheumatology Advances in Practice|December 21, 2022
Feasibility study of mobile phone photography as a possible outcome measure of systemic sclerosis-related digital lesionsAdrian K Davison, Graham Dinsdale, Paul New, et al.
Journal of Neuroinflammation|November 27, 2012
Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infectionStephen J Hopkins, Catherine J McMahon, Navneet Singh, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 19, 2021
Use of Pulmonary Computed Tomography for Evaluating Suspected Stroke-Associated PneumoniaAmit K Kishore, Anand Devaraj, Andy Vail, et al.
BMJ Open|September 24, 2020
Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort studyCarlo Berzuini, Cathal Hannan, Andrew King, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Stroke|March 24, 2018
SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 TrialCraig J Smith, Sharon Hulme, Andy Vail, et al.
Frontiers in Endocrinology|March 25, 2014
Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPA(R.)Mars Skae, Hima Bindu Avatapalle, Indraneel Banerjee, et al.
BMC Neurology|January 17, 2004
Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcomeCraig J Smith, Hedley C A Emsley, Carole M Gavin, et al.
Journal of Neuroimmunology|June 12, 2003
An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosisHedley C A Emsley, Craig J Smith, Carole M Gavin, et al.
Pageof 14